首页|不同剂量的丙种球蛋白治疗重症肺炎患儿临床疗效及对免疫球蛋白和炎症因子水平的影响

不同剂量的丙种球蛋白治疗重症肺炎患儿临床疗效及对免疫球蛋白和炎症因子水平的影响

扫码查看
目的 探究不同剂量丙种球蛋白对重症肺炎患儿临床疗效及免疫、炎症水平的影响。方法 回顾性分析2021年1月至2024年4月浙江省金华市妇幼保健院收治的98例重症肺炎患儿的临床资料。所有患儿均接受重症肺炎常规治疗和丙种球蛋白治疗,根据患儿接受的丙种球蛋白剂量分为高剂量组(56例,1 g·kg-1·d-1)和低剂量组(42例,400 mg·kg-1·d-1),2组治疗周期均为10 d。观察2组患儿的临床疗效、症状改善时间(退热时间、咳嗽缓解时间、啰音消失时间、心率恢复时间)、小儿危重症评分(PICS)、免疫球蛋白(IgG、IgA、IgM)、T细胞亚群(CD4+、CD8+、CD4+/CD8+)、炎症因子[C反应蛋白(CRP)、白细胞介素-6(IL-6)、降钙素原(PCT)]、药物不良反应(恶心、腹泻、头晕头痛)。结果 高剂量组患儿的治疗有效率(96。4%)高于低剂量组(83。3%)(P<0。05);高剂量组的退热时间、咳嗽缓解时间、啰音消失时间、心率恢复时间和PICS评分[(4。4±1。3)d、(6。2±1。2)d、(6。3±1。4)d、(2。1±0。4)d、(83。5±1。1)分]均低于低剂量组[(5。8±1。0)d、(8。6±1。6)d、(7。6±1。1)d、(2。5±0。4)d、(81。7±1。0)分](P<0。05);高剂量组的IgG、IgA、IgM[(8。37±1。12)g/L、(1。36±0。31)g/L、(1。72±0。37)g/L]均高于低剂量组[(7。22±1。24)g/L、(1。07±0。29)g/L、(1。44±0。26)g/L](P<0。05);高剂量组的CD4+、CD4+/CD8+[(38。74±5。33)%、(1。54±0。36)]水平均高于低剂量组[(36。24±5。02)%、(1。34±0。29)],CD8+(25。16±4。18)%低于低剂量组(27。13±3。99)%(P<0。05);高剂量组的CRP、IL-6、PCT[(10。6±3。2)mg/L、(34。6±5。4)pg/ml、(1。3±0。3)μg/L]水平均低于低剂量组[(14。6±4。2)mg/L、(42。6±4。6)pg/ml、(2。0±0。6)μg/L];2组患儿不良反应发生率差异无统计学意义(12。5%、9。5%)(P>0。05)。结论 高剂量的丙种球蛋白对重症肺炎患儿的治疗效果更高,能有效缓解患儿的临床症状,提高免疫力,降低炎症反应,具有安全性。
Effects of different doses of gamma globulin on clinical curative effect,immunity and inflammation level in children with severe pneumonia
Objective To explore the effects of different doses of gamma globulin on clinical curative ef-fect,immunity and inflammation level in children with severe pneumonia.Methods A retrospective analysis was performed on the clinical data of 98 children with severe pneumonia who were treated with basic therapy and gamma globulin in the hospital between January 2021 and April 2024.According to different doses of gamma globulin,children were divided into a high-dose group (56 cases,1 g·kg-1·d-1) and a low-dose group (42 cases,400 mg·kg-1·d-1).All children were treated for 10 d.The clinical curative effect,improvement time of symptoms (defervescence time,cough relief time,disappearance time of rale,recovery time of heart rate),pediatric critical illness score (PICS),immunoglobulins (IgG,IgA,IgM),T cell subsets (CD4+,CD8+,CD4+/CD8+),inflammatory fac-tors[C-reactive protein (CRP),interleukin-6 (IL-6),procalcitonin (PCT)]and adverse drug reactions (nausea,diar-rhea,dizziness and headache) in the two groups were observed.Results The response rate of treatment in high-dose group was higher than that in low-dose group (96.4% vs 83.3%,P<0.05).The defervescence time,cough re-lief time,disappearance time of rale,recovery time of heart rate and PICS in high-dose group[(4.4±1.3) d,(6.2±1.2) d,(6.3±1.4) d,(2.1±0.4) d and (83.5±1.1) points]were lower than those in low-dose group[(5.8±1.0) d,(8.6±1.6) d,(7.6±1.1) d,(2.5±0.4) d,(81.7±1.0) points;P<0.05].The levels of IgG,IgA and IgM in high-dose group[(8.37±1.12) g/L,(1.36±0.31) g/L and (1.72±0.37) g/L]were higher than those in low-dose group[(7.22±1.24) g/L,(1.07±0.29) g/L,(1.44±0.26) g/L;P<0.05].The levels of CD4+and CD4+/CD8+in high-dose group[(38.74±5.33)%and (1.54±0.36)]were higher than those in low-dose group[(36.24±5.02)%,(1.34±0.29)%];while CD8+was lower than that in low-dose group[(25.16±4.18)% vs (27.13±3.99)%,P<0.05).The levels of CRP,IL-6 and PCT in high-dose group were[(10.6±3.2) mg/L,(34.6±5.4) pg/ml,and (1.3±0.3) μg/L]were lower than those in low-dose group[(14.6±4.2) mg/L,(42.6±4.6) pg/mL,and (2.0±0.6) μg/L].There was no significant difference in incidence of adverse reactions between the two groups (12.5% vs 9.5%,P>0.05).Conclusion Curative effect of high-dose gamma globulin is better in children with severe pneumonia,which can effectively alleviate clinical symptoms,en-hance immunity and reduce inflammatory response,with safety.

PneumoniaChild,hospitalizedGamma-globulinsImmune functionInflammatory factor

王倩文、苏越、詹羿

展开 >

金华市妇幼保健院儿内科,浙江金华 321000

肺炎 儿童,住院 丙种球蛋白类 免疫功能 炎症因子

2024

中国药物与临床
中国医院协会

中国药物与临床

影响因子:0.846
ISSN:1671-2560
年,卷(期):2024.24(23)